Showing results 1 to 20 of 62
next >
| Preview | Issue Date | Title / Name | Author(s) | Type |
 | May-2024 | 233P Real-world first-line (1L) treatment selection for Australian patients (pts) with hormone receptor-positive advanced breast cancer (HR+ ABC) | Wong, V.; Baron-Hay, S.E.; De Boer, R.H.; Boyle, F.; Collins, Ian M., et al | Conference Paper | |
| Sep-2024 | 998MO Nivolumab and ipilimumab combination treatment in advanced dMMR/MSI-H noncolorectal cancers: Results from the phase II MoST-CIRCUIT study | Klein, O; Gao, B; Michael, M; Zielinski, R; So, J, et al | Conference Paper | |
 | Jan-2023 | A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary | Posner, Atara; Prall, Owen Wj; Sivakumaran, Tharani; Etemadamoghadam, Dariush; Thio, Niko, et al | Journal Article | |
 | 2016 | A discrete choice experiment to examine the preferences of patients with cancer and their willingness to pay for different types of health care appointments | Wong, Shu Fen; Norman, Richard; Dunning, Trisha Lynette; Ashley, David Michael; Khasraw, Mustafa, et al | Journal Article | |
 | 2010 | A lung cancer responding to hormonal therapy | Collins, Ian M.; Nicholson, Siobhan A.; O'Byrne, Ken J.; Collins, Ian M. | Journal Article | |
 | 2019 | Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool | Phillips, Kelly-Anne; Liao, Yuyan; Milne, Roger L.; MacInnis, Robert, J.; Collins, Ian M., et al | Journal Article | |
| 2022 | Achieving equitable access to cancer care and clinical trials in regional Australia: A networked approach to expand capacity and implement COSA teletrials model | Underhill, Craig; Long, Donna; Collins, Ian M.; Brown, Stephen; Harris, Samuel, et al | Conference Paper | |
| 2020 | Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer | Loft, Matthew; Lok, Sheau Wen; De Boer, Richard H.; Malik, Laeeq; Greenberg, Sally, et al | Journal Article | |
| Jan-2023 | Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer | Loft, Matthew; Lok, Sheau Wen; De Boer, Richard; Malik, Laeeq; Greenberg, Sally, et al | Journal Article | |
 | 2016 | Anti-Mullerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations | Phillips, Kelly-Anne; Collins, Ian M.; Milne, Roger L.; McLachlan, Sue Anne; Friedlander, Michael, et al | Journal Article | |
| 2014 | Assessing and managing breast cancer risk: Clinicians' current practice and future needs | Collins, Ian M.; Steel, Emma; Mann, G Bruce; Emery, Jon D.; Bickerstaffe, Adrian, et al | Journal Article | |
 | Jun-2022 | Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry) | Gately, Lucy; Drummond, Katherine; Rosenthal, Mark; Harrup, Rosemary; Dowling, Anthony, et al | Journal Article | |
| 2016 | Breast cancer clinical quality indicators | Pitson, Graham; Matheson, Leigh; Campbell, David; Garrard, Brooke; Collins, Ian M., et al | Conference Paper | |
| 2018 | Cardiotoxicity in advanced HER2 positive breast cancer in real world Australian patients receiving HER2-targeted therapy in the first-line setting | Conduit, C.; King, Rossa; De Boer, Richard; Gibbs, Peter; Lok, Sheau Wen, et al | Conference Paper | |
| 2022 | CDK4/6 Inhibitors (CKD4/6i) in advanced hormone-receptor-positive (HR+) HER2-negative (HER2-) breast cancer: Prescribing practices and outcomes in a real-world, Australian cohort | Javaid, Anadil; Lok, Sheau Wen; Wong, Vanessa; Baron-Hay, Sally; Boyle, Fran, et al | Conference Paper | |
| 2012 | Clinical decision aids in colon cancer: a comparison of two predictive nomograms | Collins, Ian M.; Kelleher, Fergal; Stuart, Charlotte; Collins, Marnie; Kennedy, John, et al | Journal Article | |
 | 29-May-2024 | Clinical impact of molecular profiling in the national prospective cohort Solving Unknown Primary Cancer (SUPER) study. | Sivakumaran, Tharani; White, Matthew; Prall, Owen; Mitchell, Catherine; Dijkstra, Christine, et al | Conference Paper | |
| 2019 | Clinical impact of tissue of origin testing and mutation profiling in the Solving Unknown Primary Cancer (SUPER) national prospective study: Experience of the first two years | Mileshkin, Linda R.; Sivakumaran, Tharani; Etemadmoghadam, Dariush; Tothill, Richard; Fellowes, Andrew, et al | Conference Paper | |
| 10-Nov-2023 | A combined analysis of two randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma | Gately, Lucy; Mesia, Carlos; Sepulveda, Juan; del Barco, Sonia; Pineda, Estela, et al | Conference Paper | |
| 2019 | Consumer and clinician perspectives on personalising breast cancer prevention information | Keogh, L. A.; Steel, E.; Weideman, P.; Butow, P.; Collins, Ian M., et al | Journal Article | |
